JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (2005) 187, 225-235       DOI: 10.1677/joe.1.06413
© 2005 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richards, S K
Right arrow Articles by Smith, R M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richards, S K
Right arrow Articles by Smith, R M

Over-expression of AMP-activated protein kinase impairs pancreatic ß-cell function in vivo

S K Richards, L E Parton1, I Leclerc1, G A Rutter1 and R M Smith

Richard Bright Renal Unit, Southmead Hospital, Bristol BS10 5NB, UK
1 Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University Walk, University of Bristol, Bristol BS8 1TD, UK

(Requests for offprints should be addressed to G A Rutter; Email: g.a.rutter{at}bris.ac.uk)

Treatment of type 1 diabetes by islet transplantation is currently limited by loss of functional ß-cell mass after transplantation. We investigated here whether adenovirus-mediated changes in AMP-activated protein kinase (AMPK) activity, previously shown to affect insulin secretion in vitro, might affect islet graft function in vivo. In isolated mouse and rat islets, insulin secretion stimulated by 17 (vs 3) mmol/l glucose was inhibited by 36.5% (P<0.01) and 43% (P<0.02) respectively after over-expression of constitutively-active AMPK- (AMPK CA) versus null (eGFP-expressing) viruses, and glucose oxidation was decreased by 38% (P<0.05) and 26.6% (P<0.05) respectively. Increases in apoptotic index (terminal deoxynucleotide transferase-mediated deoxyuridine trisphosphate biotin nick end-labelling) (TUNEL)) were also observed in AMPK CA- (22.8 ± 3.6% TUNEL-positive cells, P<0.001), but not AMPK DN- (2.72 ± 3.9%, positive cells, P=0.05) infected islets, versus null adenovirus-treated islets (0.68 ± 0.36% positive cells). Correspondingly, transplantation of islets expressing AMPK CA into streptozotocin-diabetic C57 BL/6 mice improved glycaemic control less effectively than transplantation with either null (P<0.02) or AMPK-DN-infected (P<0.01) islets. We conclude that activation of AMPK inhibits ß-cell function in vivo and may represent a target for therapeutic intervention during islet transplantation.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
F. Zhang, D. Dey, R. Branstrom, L. Forsberg, M. Lu, Q. Zhang, and A. Sjoholm
BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner
Am J Physiol Cell Physiol, February 1, 2009; 296(2): C346 - C354.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Zhou, X. Wang, L. Shao, Y. Yang, W. Shang, G. Yuan, B. Jiang, F. Li, J. Tang, H. Jing, et al.
Berberine Acutely Inhibits Insulin Secretion from {beta}-Cells through 3',5'-Cyclic Adenosine 5'-Monophosphate Signaling Pathway
Endocrinology, September 1, 2008; 149(9): 4510 - 4518.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M Blandino-Rosano, G Perez-Arana, J M Mellado-Gil, C Segundo, and M Aguilar-Diosdado
Anti-proliferative effect of pro-inflammatory cytokines in cultured {beta} cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1
J. Mol. Endocrinol., July 1, 2008; 41(1): 35 - 44.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S.-J. Kim, C. Nian, D. J. Doudet, and C. H.S. McIntosh
Inhibition of Dipeptidyl Peptidase IV With Sitagliptin (MK0431) Prolongs Islet Graft Survival in Streptozotocin-Induced Diabetic Mice
Diabetes, May 1, 2008; 57(5): 1331 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Riboulet-Chavey, F. Diraison, L. K. Siew, F. S. Wong, and G. A. Rutter
Inhibition of AMP-Activated Protein Kinase Protects Pancreatic {beta}-Cells From Cytokine-Mediated Apoptosis and CD8+ T-Cell-Induced Cytotoxicity
Diabetes, February 1, 2008; 57(2): 415 - 423.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
P. D. Mountjoy and G. A. Rutter
Glucose sensing by hypothalamic neurones and pancreatic islet cells: AMPle evidence for common mechanisms?
Exp Physiol, March 1, 2007; 92(2): 311 - 319.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Arumugam, D. Fleenor, and M. Freemark
Lactogenic and Somatogenic Hormones Regulate the Expression of Neuropeptide Y and Cocaine- and Amphetamine-Regulated Transcript in Rat Insulinoma (INS-1) Cells: Interactions with Glucose and Glucocorticoids
Endocrinology, January 1, 2007; 148(1): 258 - 267.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Hurley, L. K. Barre, S. D. Wood, K. A. Anderson, B. E. Kemp, A. R. Means, and L. A. Witters
Regulation of AMP-activated Protein Kinase by Multisite Phosphorylation in Response to Agents That Elevate Cellular cAMP
J. Biol. Chem., December 1, 2006; 281(48): 36662 - 36672.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.